Medicinal Chemistry
Compound Screening
DMPK
Safety & Toxicology
Bioanalytical
CMC
Medical Writing
Clinical Monitoring
Regulatory Affairs
Data Management and Statistical Analysis
Clinical Development Strategy
Site Management (SMO)
Subject Recruitment
Medical Device / IVD
Multi-region Clinical Trial (MRCT)
Vaccine Clinical Trial
ESG
Sustainability & ESG Report
We create sustainable values. We live our values.
Contributing to Global Health and Well-being
Tigermed’s mission is to “Advance human health through delivery excellence”, based on which it focuses on solving the most challenging global health problems, meeting the unmet medical needs of patients, creating social value and benefiting human health.
As a pioneer in the globalization of clinical CRO in China, Tigermed has close customers and industry partners as well as a senior professional management team to constantly explore innovative solutions to meet the diverse needs of our customers and make greater contributions to pharmaceutical innovation and R&D to create social value.
Protecting the Environment
0.28 tons
CO2 equivalent GHG emissions per capita
100%
Compliance rate of waste disposal
0
Number of environmental safety accidents
Committed to Social Responsibility
5.73MCNY
Social welfare donations in 2022
10,000copies
Support the Clinical Research Promotion Foundation to publish the Handbook for Drug Clinical Trial Subjects and give away books in various ways
Life Chart
Released a public service themed microfilm in tribute to all clinical trial participants
Focused on Innovation
Innovation Pioneers
Promote a culture of innovation and the cultivation of innovative talents
40digital projects
6 of the projects were awarded as outstanding innovation projects, including RBQM, DCT, E-SITE, CTMS
Innovation Center
Promote diversified innovation in services, operations, management and technology
Sustaining Employee Engagement
63%
Percentage of female employees in senior management
89.5%
Retention rate of key employees in domestic clinical trials
100%
Percentage of employees trained &
Percentage of employees trained for business ethics
Source: 2022 Tigermed Sustainability Report and Environmental, Social and Governance Report
Tigermed’s Sustainable Development Strategies
As a leading integrated biopharmaceutical R&D service platform, Tigermed continues to support and contribute to the United Nations Sustainable Development Goals (SDGs), forging ahead with fortitude taking “Contributing to global health and well-being” as the core. While realizing our economic growth and sustainable development, the Company identify 4 key aspects of sustainable development related to our own operations and growth, and draw up corresponding strategic guidelines for the four key areas.
The site uses cookies in order to collect data to provide general statistics to optimize site functionality and offer you a better experience. For more information, visit our Privacy Policy.